4.8 Article

Precise magnetic resonance imaging-guided sonodynamic therapy for drug-resistant bacterial deep infection

期刊

BIOMATERIALS
卷 264, 期 -, 页码 -

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2020.120386

关键词

Porphyrin; Peptide; Self-assembly; Sonodynamic; Drug-resistant bacteria

资金

  1. National Natural Science Foundation of China [21674027, 21704020, 31870998, 51725302, 11621505, U1604139, 21771055]
  2. Strategic Priority Research Program of Chinese Academy of Sciences [XDB36000000]
  3. Beijing Nova Program of Science and Technology [Z191100001119091]
  4. Beijing Zhongkebaice Technology Service Co., Ltd.

向作者/读者索取更多资源

The study introduces a novel approach for treating drug-resistant deep bacterial infections using a polymer-peptide-porphyrin conjugate (PPPC) to achieve accurate and deep sonodynamic therapy (SDT). PPPC can be monitored in real-time at the infectious site and effectively eliminates drug-resistant bacteria, showing promising applications in the field.
The precise treatment of drug-resistant deep bacterial infections remains a huge challenge in clinic. Herein, a polymer-peptide-porphyrin conjugate (PPPC), which can be real-time monitored in infectious site, is developed for accurate and deep sonodynamic therapy (SDT) based on in vivo self-assembly strategy. The PPPC contains four moieties, i.e., a hyperbranched polymer backbone, a self-assembled peptide linked with an enzymecleavable peptide-poly (ethylene glycol) terminal, a bacterial targeting peptide, and a porphyrin sonosensitizer (MnTCPP) segment. Once PPPC nanoparticles reach the infectious area, the protecting PEG layers are removed due to the over-expressed gelatinase, leading to the secondary assembly into large nanoaggregates and resultant enhanced accumulation of sonosensitizer. The nanoaggregates exhibit enhanced interaction with bacterial membrane and decrease the minimum inhibitory concentration (MIC) significantly. Meanwhile, compared with free MnTCPP, the concentration of which can not be accurately quantified, the accumulation amount of MnTCPP in PPPCs at infectious site can be in situ monitored by magnetic resonance imaging (MRI) using T-1 combined with T-2. When the concentration of PPPC-1 reaches MIC, the drug-resistant bacterial infection area is exposed to ultrasound irradiation, causing the precise and efficient elimination of bacteria. Therefore, the MRI-guided SDT system shows extraordinary tissue penetration depth, drug concentration monitoring, morphology-transformation induced accumulation and improved treatment capacity toward drug-resistant bacteria.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据